Stocks and Investing
Stocks and Investing
Thu, June 11, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, June 10, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tazeen Ahmad Maintained (SRPT) at Strong Buy and Held Target at $180 on, Jun 10th, 2020
Tazeen Ahmad of B of A Securities, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $180 on, Jun 10th, 2020.
Tazeen has made no other calls on SRPT in the last 4 months.
There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Tazeen's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Tazeen
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $172 on, Wednesday, April 15th, 2020
- Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $183 on, Tuesday, March 31st, 2020
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $160 on, Friday, February 28th, 2020
- Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $217 on, Thursday, February 27th, 2020